Olympiad Research LP Makes New Investment in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Olympiad Research LP purchased a new stake in Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 7,521 shares of the semiconductor company's stock, valued at approximately $789,000.

Other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in Axcelis Technologies by 6.5% in the first quarter. Vanguard Group Inc. now owns 4,304,516 shares of the semiconductor company's stock worth $480,040,000 after purchasing an additional 263,604 shares in the last quarter. Reinhart Partners LLC. grew its stake in Axcelis Technologies by 64.1% during the 3rd quarter. Reinhart Partners LLC. now owns 687,608 shares of the semiconductor company's stock worth $72,096,000 after buying an additional 268,560 shares during the last quarter. Boston Trust Walden Corp acquired a new position in Axcelis Technologies during the 3rd quarter valued at about $53,099,000. Jackson Square Partners LLC raised its stake in Axcelis Technologies by 49.0% in the first quarter. Jackson Square Partners LLC now owns 492,764 shares of the semiconductor company's stock valued at $54,953,000 after buying an additional 162,040 shares during the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its holdings in Axcelis Technologies by 7.7% in the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 455,846 shares of the semiconductor company's stock worth $64,816,000 after acquiring an additional 32,695 shares in the last quarter. Hedge funds and other institutional investors own 89.98% of the company's stock.

Axcelis Technologies Price Performance

Shares of ACLS stock traded down $0.85 during mid-day trading on Thursday, hitting $87.10. 1,262,202 shares of the stock were exchanged, compared to its average volume of 628,695. Axcelis Technologies, Inc. has a 52-week low of $82.97 and a 52-week high of $158.61. The company has a quick ratio of 3.26, a current ratio of 4.42 and a debt-to-equity ratio of 0.05. The company has a market cap of $2.84 billion, a PE ratio of 12.11, a price-to-earnings-growth ratio of 2.60 and a beta of 1.60. The firm has a fifty day moving average of $97.85 and a 200 day moving average of $113.40.

Analysts Set New Price Targets

ACLS has been the topic of several recent analyst reports. Benchmark cut their price objective on shares of Axcelis Technologies from $180.00 to $175.00 and set a "buy" rating on the stock in a report on Friday, August 2nd. Bank of America lifted their price objective on shares of Axcelis Technologies from $125.00 to $150.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 10th. Needham & Company LLC restated a "hold" rating on shares of Axcelis Technologies in a research note on Friday, August 2nd. B. Riley dropped their target price on Axcelis Technologies from $190.00 to $165.00 and set a "buy" rating on the stock in a research report on Friday, August 2nd. Finally, DA Davidson increased their price objective on shares of Axcelis Technologies from $150.00 to $175.00 and gave the stock a "buy" rating in a research note on Monday, July 15th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $167.33.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.